Nuclear Receptor Research is a peer-reviewed open access journal that publishes high-quality, original research and review articles covering all aspects of research involving all members of the nuclear receptor superfamily.
Open Access is allowing unrestricted re-use of the content by making use of CC-BY licensing, also provides immediate, worldwide, barrier-free access via the internet to the full text of peer-reviewed scholarly journal articles without requiring a subscription to the journal in which these articles are published. The journal allows the authors to retain unrestricted copyright to their articles.
The journal fosters communication of information among scientific professors and their communities around the world, in an open access format with immediate online dissemination.
Manuscripts should be submitted by one of the authors of the manuscript through the Manuscript Management System of Nuclear Receptor Research. Regardless of the source of the word-processing tool, only electronic PDF (.pdf) or Word (.doc, .docx, .rtf) files can be submitted through the Manuscript Management System. Only online submissions are accepted to facilitate rapid publication and minimize administrative costs. Submissions by anyone other than one of the authors will not be accepted. The submitting author takes responsibility for the paper during submission and peer review. If for some technical reason submission through the Manuscript Management System is not possible, the author can contact firstname.lastname@example.org for support.
Manuscripts should generally be arranged in the following order:
The first page of any manuscript shall include the title, name(s) of authors, their institutional affiliations and addresses, city and country (zip codes, if applicable). The title of the article is typed in bold capitals. Title must be within one hundred characters (including spaces) and descriptive of the contents of the manuscripts. Authors should be listed with initial names first followed by their surnames. Addresses (including emails) should be listed under the names of authors. Where authors work at different addresses, they should be identified by numbered superscripts against their names. References to professional qualifications/titles are not required. The first author will be assumed to be the contact person unless otherwise stated.
The abstract is a concise abbreviated version of the paper which tells the reader whether the paper is worth reading at all; it must therefore be informative with respect to aim, methods, procedures, results, discussion, and conclusion. An abstract should not exceed 200 words.
A maximum of five keywords (separated by comma) that best describe the material being presented must follow the abstract.
The introduction should follow the key words and should be as brief as possible; it should concern itself with a clear justification for the work undertaken and the underlying theory and hypothesis; a short review of literature in the field of study is obligatory although any exhaustive review properly belongs to the Discussion section.
This section describes concisely the methodology/procedures employed so that anyone wishing to replicate the trial can do so and obtain comparable results. Provide sufficient detail so as to remove any possible ambiguities with respect to design, treatments, measurements, analysis, etc. Where methods employed are commonly known in a given field details should be omitted and the reference given instead. Modifications to known methodology must however be clearly described and explained.
This section describes clearly the observations made and their concise interpretation; the discussion is probably the single most important section. While the two sections (Results and Discussion) may be separated, it is generally advisable to combine them to facilitate easy discussion of the results without having to repeat the results. Results should be presented in tables and/or figures whenever possible, but should be clearly explained in the text taking care to avoid unnecessary repetition of tabular data. Information presented in tables should not be repeated in figures, or vice versa. Standard deviations/errors help the reader to follow the trend of results and should be supplied whenever appropriate. The discussion should interpret observations – i.e. explain the causes of events – and not simply state the obvious. The discussion should include references to earlier or contemporary literature relevant to the topic studied; this way, a reviewer can decide on the merits of the manuscript.
Tables are to be numbered according to their sequence in the text and should also be referred to in the text before they are placed. The tables should be inserted at the exact positions where they belong in the body of the paper. All tables must have short but self-explanatory titles. Table numbers and titles should be placed at the top left of the tables. Arabic numerals are to be used. Tables should be numbered from Table 1 and continued serially to 2, 3, etc.
Figures should be inserted at the exact positions where they belong in the body of the paper and should also be referred to in the text before they are placed. They should be clearly captioned and numbered in sequence below each figure. Figures should be supplied in either vector art formats (Illustrator, EPS, WMF, FreeHand, CorelDraw, PowerPoint, Excel, etc.) or bitmap formats (PhotoShop, TIFF, GIF, JPEG, etc.). Bitmap images should be of 300 dpi resolution at least unless the resolution is intentionally set to a lower level for scientific reasons. If a bitmap image has labels, the image and labels should be embedded in separate layers. Figures should be numbered from 1 and continued serially to 2, 3, etc.
Footnotes to tables should be superscript numbers (1) while superscript letters (a) should be reserved for statistical analysis; asterisks (*) are reserved for probability values. Footnotes to the title page (including title, authors, addresses, etc) are numbered sequentially from the beginning. Footnotes should be used sparingly and only if absolutely required, otherwise the information should be embodied in the text of the paper.
Authors are responsible for ensuring that the information in each reference is complete and accurate. All references must be numbered consecutively and citations of references in text should be identified using numbers in square brackets (e.g., “as discussed by Smith ”“as discussed elsewhere [9, 10]”). All references should be cited within the text; otherwise, these references will be automatically removed.
Latin words used to identify biological structures or entities are always italicised; similarly phrases like et al., in situ, in vivo, versus, per se. On the other hand, commonly used abbreviations such as etc., viz. and e.g. do not require italicisation.
As a rule, numerals are not used to start sentences; words are preferred. In addition, words should be used for all numbers less than 10 and numerals for those greater than 10. In the situation where a sequence of numbers is given with some less and others more than 10 (e.g. 150, 90, 45, 17, 9, 3), the use of numerals for all is advised. If a number is followed immediately by a unit of measurement, use the numeral, e.g., 2g; 3cm.
The metric system (SI) of measure is obligatory.
All manuscripts are subject to peer review by a number of the editorial board members and are expected to meet standards of academic excellence.
Galley proofs of all accepted manuscripts are sent to the senior author (or as indicated in the original manuscript) who should check for typographical errors and answer queries raised by the technical compositor. The checked proofs should be returned to the technical compositor via the journal Manuscript Management System of Nuclear Receptor Research. The publisher will do everything possible to ensure prompt publication. It will therefore be appreciated if the manuscripts and figures conform from the outset to the style of the journal.
The Editorial Board of Nuclear Receptor Research assumes no responsibility for statements made or opinions expressed by authors who should ensure that all submitted manuscripts have resulted from their own original work.
There is no page limit.
All parties involved in a publication (i.e. the authors, reviewers, and editors) should transparently declare any potential Competing Interests (also known as Conflicts of Interest). The disclosure of a Competing Interest does not necessarily mean that there is an issue to be addressed; it simply ensures that all parties are appropriately informed of any relevant considerations while they work on the submission.
Potential competing interests should be declared even if the individual in question feels that these interests do not represent an actual conflict. Examples of Competing Interests include, but are not limited to: possible financial benefits if the manuscript is published; prior working, or personal, relationships with any of the authors; patent activity on the results; consultancy activity around the results; personal material or financial gain (such as free travel, gifts, etc.) relating to the work; personal convictions (religious, political, etc.) which may have a bearing on the work, and so on.
Authors MUST follow ethical means of undertaking research, acquiring data, and presenting information. We require that our authors reveal all possible conflicts of interest in their submitted manuscripts.
You can visit our Ethical Issues and Disclosure Policy web page to read more about this policy.